| 1.92 0.02 (1.05%) | 10-01 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.36 | 1-year : | 2.52 |
| Resists | First : | 2.02 | Second : | 2.16 |
| Pivot price | 1.95  |
|||
| Supports | First : | 1.79 | Second : | 1.49 |
| MAs | MA(5) : | 1.9 |
MA(20) : | 1.95 |
| MA(100) : | 1.87 |
MA(250) : | 2.48 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 14.9 |
D(3) : | 15.4 |
| RSI | RSI(14): 49.3 |
|||
| 52-week | High : | 7.9 | Low : | 0.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CDIO ] has closed above bottom band by 34.6%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.95 - 1.96 | 1.96 - 1.97 |
| Low: | 1.86 - 1.87 | 1.87 - 1.87 |
| Close: | 1.91 - 1.92 | 1.92 - 1.93 |
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Fri, 18 Sep 2026
Potential 20% share dilution cleared for Cardio Diagnostics (NASDAQ: CDIO) - Stock Titan
Wed, 05 Aug 2026
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 - Business Wire
Tue, 30 Jun 2026
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - Yahoo Finance
Wed, 24 Jun 2026
Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network - Business Wire
Tue, 23 Jun 2026
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance
Mon, 20 Apr 2026
Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch' - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 2.84e+006 (%) |
| Held by Institutions | 8.3 (%) |
| Shares Short | 5 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.08e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -27 % |
| Return on Assets (ttm) | 950.5 % |
| Return on Equity (ttm) | -44.1 % |
| Qtrly Rev. Growth | 14450 % |
| Gross Profit (p.s.) | -12.7 |
| Sales Per Share | -33.83 |
| EBITDA (p.s.) | 6479.82 |
| Qtrly Earnings Growth | -3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.06 |
| Price to Cash Flow | 1.7 |
| Dividend | 0 |
| Forward Dividend | 29570 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|